-
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Given Average Recommendation of "Moderate Buy" by Analysts
ソース: Buzz FX / 05 10 2024 02:06:12 America/New_York
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Given Average Recommendation of "Moderate Buy" by Analysts Written by MarketBeat October 5, 2024 Share Link copied to clipboard. Shares of Halozyme Therapeutics, Inc.
Read more...